A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms.
about
PPARs and the cardiovascular systemGenomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency.A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle CellsPPAR gamma and human metabolic diseaseVascular smooth muscle cell peroxisome proliferator-activated receptor-γ mediates pioglitazone-reduced vascular lesion formationThe link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoformPPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.PPAR-gamma in the Cardiovascular SystemPeroxisome proliferator-activated receptors and atherosclerosis.Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis.Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling.Protective Actions of PPAR-gamma Activation in Renal Endothelium.Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha.Effect of the Capsicoside G-rich Fraction from Pepper (Capsicum annuum L.) Seeds on High-fat Diet-induced Obesity in Mice.
P2860
Q24642728-F85C62C3-7E04-4014-A814-084320FD2E5AQ28476779-CA7D0B8C-2BD4-47CB-B245-67F1BE478168Q33642053-0BFECF81-6602-4A6A-B32F-5371D6535477Q33642887-7A5EDCD1-1215-47E2-85D0-89016E521CB8Q33724886-D6846C6A-AC9A-4F34-806D-00EDA0EE2FD4Q34416432-17C77E85-2BDB-4BC0-84AF-47FB4213AE51Q34796331-C6E97296-93EB-4685-A499-6ED11B590273Q35004514-6200147F-EC8C-4A84-858C-DF4A8547DD05Q36388875-EF573B27-1728-46AA-8A9F-ABFD602DD414Q36426786-116EF46E-7939-4D00-AE77-A0702FF5968FQ37861955-A686958B-3A86-400A-B03E-4B4FD5CDC696Q38346897-2C23866C-466A-4E01-A41C-23C917D88794Q39655083-C9C7FD8D-99CC-4F56-85EB-03E5DC02DBEDQ42008239-9D81E4F0-8CB0-4C1A-B07B-FF1AE07F0C29Q48370446-AF421393-0CD7-4B7C-AFE5-9A7FC5AC9A45Q51563641-D35706C1-40E9-49F7-BF39-EC625FE5D95D
P2860
A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A dominant negative human pero ...... ing through all PPAR isoforms.
@en
type
label
A dominant negative human pero ...... ing through all PPAR isoforms.
@en
prefLabel
A dominant negative human pero ...... ing through all PPAR isoforms.
@en
P2093
P356
P1433
P1476
A dominant negative human pero ...... ing through all PPAR isoforms.
@en
P2093
Chatterjee VK
Gibbons GF
Meirhaeghe A
O'Rahilly S
Schwabe JW
Vidal-Puig AJ
P304
P356
10.1210/EN.2004-1405
P407
P577
2005-01-20T00:00:00Z